UJA-71804-85868
2 vaccinations
3 coded responses
7 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 923 / CA
- Registered
- 2021-03-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-13
Dose 1 — Pfizer-BioNTech
-
2021-03-15
Registered in v-safe
-
2021-03-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Fever · NoneAdult check-in
-
2021-03-16
Survey response — days 1–6 daily, dose 1MedDRA: Neck pain — Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Nausea, Vomiting · Be unable to do your normal daily activitiesFree text: Neck PainMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-16
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-03-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fever · Headache, Nausea, VomitingAdult check-in
-
2021-04-03
Dose 2 — Pfizer-BioNTech
-
2021-04-03
Survey response — day 0, dose 2MedDRA: Blood pressure increased, Heart rate increased — Feeling: Poor · Fever · Nausea, Vomiting, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Increased Heart Rate and Blood PressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-06
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, Abdominal painAdult check-in
-
2021-07-03
Survey response — 3 months, dose 2MedDRA: Dyspnoea, Palpitations — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Heart racing and breathlessnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-13 | Pfizer-BioNTech | |
| 2 | 2021-04-03 | Pfizer-BioNTech |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Neck Pain
Release 6 — day 0, dose 2
Systemic reaction (other): Increased Heart Rate and Blood Pressure
Release 9 — 3 months, dose 2
Symptoms: Heart racing and breathlessness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Palpitations | ✓ | ✓ | ✓ |
| SRO | Blood pressure increased | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Neck pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release